CTRI/2020/06/025789已完成未知
Role Of Very Low Dose Of Factor IX Prophylaxis In Severe Hemophilia B Patients
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with age greater than 13 years diagnosed as Severe Hemophilia B.
排除标准
- •Patients with other bleeding disorders like Von Willebrands Disease
- •Patients with any liver disease or kidney disease
- •Patients on anticoagulation therapy
研究者
相似试验
尚未招募
不适用
Prophylactic Therapy In Hemophilia ACTRI/2020/07/026880Maulana Azad Medical College
Unknown
不适用
A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing SurgeryHemophilia CNCT01538160Sheba Medical Center15
进行中（未招募）
1 期
Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia BHemophilia BNCT01687608Baxalta now part of Shire30
招募中
不适用
The effect of recombinant Factor IX-FIAV in In-vitro thrombin generation in hemophilia A patient samplesHemophilia ANL-OMON47946Erasmus MC, Universitair Medisch Centrum Rotterdam21
进行中（未招募）
1 期
Study of a new medicinal factor IX product, IB1001, to treat patients with hemophilia BEUCTR2010-024190-39-GBAptevo Europe Limited22